Results indicated a higher and similar prevalence of titin autoantibodies in both late‐onset myasthenia gravis and thymoma myasthenia gravis when compared to early‐onset non‐thymoma myasthenia gravis; however, the implications of these findings on malignancy behavior and recurrence potential is not yet understood. Here, TTN is linked to myasthenia gravis.